Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. You can reach Adam on Signal at stataf.54. MoonLake Immunotherapeutics’ management team could not stop spinning Sunday, even …
Read More »MoonLake’s Phase 3 trials for autoimmune skin condition miss mark
